May 10, 2017 | Medical Communications, medical education, rare diseases, recruitment
As pharma becomes more focused on rare disease therapies, Lucid Group recognises that medical education agencies need to respond.

The US government passed the Orphan Drug Act in 1983, and it was subsequently adopted in other key markets, most notably in Japan in 1993 and the European Union in 2000. Growth in this sector has remained around 12% annually, which is more than double that experienced in the general drug market. According to the 2015 Orphan Drug Report, worldwide orphan drug sales will reach $178 billion by 2020 and will account for 20% of all prescription drug sales by 2020*.
The trend is clear: as science and technology advances, and the rise of the internet and social media enables patients and researchers to gather and share information more effectively, we are seeing treatments for rare diseases that only a few years ago would have led to an early death.
Alison Cantle, Rare Disease Business Unit Director at Lucid Group, explains what this means for medical education agencies: “As pharmaceutical organisations focus on personalised medicine, the need for rare disease expertise in their medical education agencies is paramount. Lucid recognised this and structured its business last year to create a unit specialising in rare diseases.”
Within this unit, Lucid Group had recruited a team of highly skilled medical writers who combine a deep and robust understanding of the science with experience of working with rare disease specialists across the globe.
“Our rare disease team understands the cornerstones of rare disease education and what makes it different from other therapy areas. It is essential to build networks and enable best practice sharing,” Alison explains. “And in rare disease, more so than in any other therapy area, the choice of agency is crucial, as often it is your agency who represents your organisation at the communication level – so its voice has to be your voice.”
Patients who have a rare disease face difficulty in every step of medical care, including diagnosis, treatment and preserving quality of life. Sometimes, patients go years without receiving the correct diagnosis for their condition. So raising awareness, improving time to diagnosis, getting patients to the right care, and improving family and emotional support and reimbursement are just some of the areas where medical education agencies can support pharma clients.
Lucid’s Rare Disease Business Unit currently works with clients in Fabry disease, Pompe disease, Gaucher disease, cystinosis and PKU. For further information about working with Lucid’s Rare Disease Business Unit, please call Alison on 01494 552078 or email alison@lucid-uk.com.
* EvaluatePharma Orphan Drug Report 2015
This content was provided by Lucid Group Communications Limited
Company Details
Latest Content from Lucid Group Communications Limited
Lighthouse Medical Communications US, part of the award-winning Lucid Group of companies, is pleased to announce the appointment of Marc Pondel, PhD as Executive Medical Science Director. Marc will oversee...
Vivid Medical Communications – a newly created rare diseases specialist agency and part of the successful Lucid Group of companies – is a proud supporter of Rare Diseases Day 2018.
The Lucid ‘Festival of Magic’ was a celebration of their pioneering work and the people that made it possible.
Lucid Group celebrated their eleventh birthday today. They served up plenty of cake and excitement, distributing invitations for family and friends to attend the Lucid Magic festival, which is being...
Lucid launch their new company branding
This week Business Unit Heads from Lucid Group met with potential candidates at their Macclesfield office to interview for a number of key roles within the organisation. The recruitment drive...
Lucid held their first breakfast meeting with top industry recruiters from across the UK to discuss their plans for expansion and recruitment for the year ahead. CEO and Co-Founder Dennis...
After the success of last year’s Futures Academy, a new intake of graduates is fulfilling their dreams and ambitions as they embark this week on an intensive eight-week training course...
In the frosty sunlight of a winter morning, employees from across the Lucid Group gathered to celebrate a magical year of success at the Lucid Annual Winter Meeting. Traditionally being...
